MedPath

A Randomized-controlled Study of a Cognitive-behavioral Intervention for Children With Functional Abdominal Pain

Not Applicable
Completed
Conditions
Abdominal Pain
Functional Abdominal Pain Syndrome
Interventions
Behavioral: Intervention group
Behavioral: Active control group
Registration Number
NCT02030392
Lead Sponsor
University of Potsdam
Brief Summary

This trial aims to compare two training programs for children suffering functional abdominal pain. These two programs are comparable in number of sessions and group sizes, but show differences in content (very focused on pain management vs. more general information and support). Focus of the trial is the evaluation of "Stop the pain", which has shown high effectiveness in one first trial. This time, five clinics, experienced in diagnosis and treatment of childhood chronic abdominal pain, will take part. Children aged 7-12 years are eligible. The programs imply six weekly group sessions for the children and 2 parent evenings. The study group assumes that participation in "Stop the pain" will reduce pain experience and will improve the children's quality of life and coping strategies - up to 12 months after training.

Detailed Description

The trial aims to assess the efficacy of a cognitive-behavioral self-management program (intervention group, IG) compared to an equally extensive information-only control group (CG). The interventions contain 6 weekly group sessions and 2 parent meetings according to the cognitive-behavioral, manualized program "Stop the pain with Happy Pingu". Follow up per patient: 3- and 12 months. Children aged 7-12 years suffering functional abdominal pain (according to Rome III criteria H2a, H2b, H2d, H2d1) are eligible. Our primary hypothesis is that for patients in the IG the frequency and intensity of pain will be reduced more successfully and more sustainable than for children in the CG. Secondary hypotheses state that the IG will experience a higher increase in quality of life and psychosocial well-being compared to the active CG.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
127
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupIntervention groupIG participation in the cognitive-behavioral program "Stop the pain with Happy Pingu". The program compromises six weekly sessions for the children in small groups (90 min each) and 2 sessions for the parents (90 min each).
Active control groupActive control groupCG participation in an information and education control group (physical well-being, health and gastrointestinal tract). The program of the control group compromises six weekly sessions for the children in small groups (90 min each) and 2 sessions for the parents (90 min each).
Primary Outcome Measures
NameTimeMethod
Change in Pain Symptomsup to 21 days pre intervention, up to 21 days post intervention, 3 month-follow-up, 12 month-follow-up

Primary efficacy endpoint is the frequency and intensity of pain (composite score) over the course of treatment and follow-up (pre, post, 3 and 12 months follow-up). This primary outcome will be assessed by pain diary in children's self-report (over 2 weeks).Statistically, the primary endpoint of the study is defined as the change of the logarithm of the area under the pain-intensity curve over one week from start of treatment to 12 month follow-up. The area under the pain intensity curve (auc) is a measure that reflects pain intensity as well as pain duration and pain frequency and thus can be understood as a composite measure of pain.

Secondary Outcome Measures
NameTimeMethod
Pain-related impairmentup to 21 days pre intervention, up to 21 days post intervention, 3 month-follow-up, 12 month-follow-up

A measure for child's functional disability due to pain. The measure is one scale score and covers the level of impairment in everyday activitites due to abdominal pain by 12 items, e.g. reading, meeting friends, family life. The secondary outcome variable will be assessed by self-report questionnaire (pre, post, 3- and 12 months follow-up).

Pain-related coping and cognitionsup to 21 days pre intervention, up to 21 days post intervention, 3 month-follow-up, 12 month-follow-up

The secondary outcome variable will be assessed by self-report questionnaire (pre, post, 3- and 12 months follow-up).

Health-related quality of lifeup to 21 days pre intervention, up to 21 days post intervention, 3 month-follow-up, 12 month-follow-up

The secondary outcome variable will be assessed by self-report questionnaire (pre, post, 3- and 12 months follow-up).

Trial Locations

Locations (4)

Catholic Children's Hospital Hamburg Wilhelmstift

🇩🇪

Hamburg, Germany

University Medical Center, Pediatric Gastroenterology

🇩🇪

Ulm, Germany

St. Vincenz Hospital

🇩🇪

Paderborn, Germany

Children's Hospital "Prinzessin Margaret", Pediatric Gastroenterology

🇩🇪

Darmstadt, Germany

© Copyright 2025. All Rights Reserved by MedPath